Working… Menu
Help guide our efforts to modernize
Send us your comments by March 14, 2020.

Treating Acute MI Patients With Aggrastat on Their Way to Hospital

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00300833
Recruitment Status : Unknown
Verified January 2009 by The Baruch Padeh Medical Center, Poriya.
Recruitment status was:  Recruiting
First Posted : March 10, 2006
Last Update Posted : August 11, 2011
Information provided by:
The Baruch Padeh Medical Center, Poriya

Brief Summary:
Treating an AMI patient with ST elevation with Aggrastat in the ambulance on his or her way to the hospital.

Condition or disease Intervention/treatment Phase
Acute Myocardial Infarction Drug: Tirofiban Phase 4

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 200 participants
Allocation: Non-Randomized
Intervention Model: Single Group Assignment
Masking: None (Open Label)
Primary Purpose: Treatment
Study Start Date : January 2006
Estimated Primary Completion Date : January 2012

Resource links provided by the National Library of Medicine

Drug Information available for: Tirofiban

Intervention Details:
  • Drug: Tirofiban

Primary Outcome Measures :
  1. mortality [ Time Frame: immidiately ]

Secondary Outcome Measures :
  1. TIMI flow [ Time Frame: 24 hours ]
    feeling better

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Layout table for eligibility information
Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No

Inclusion Criteria:

patients with acute Myocardial infarction with ST elevation , and moving by ambulance to Poriya hospital

Exclusion Criteria:

  • women less than 50 years old and 80 years old, bleeding tendency, stroke in the past

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its identifier (NCT number): NCT00300833

Layout table for location contacts
Contact: Yonathan Hasin, Professor 97246652648

Layout table for location information
Cardiovascular Division, The Baruch Padeh Medical Center, Poriya, Recruiting
Tiberias, Israel, 15208
Magen David , Recruiting
Tiberias, Israel
Contact: Sergay Krablikov, Dr         
Sponsors and Collaborators
The Baruch Padeh Medical Center, Poriya
Layout table for investigator information
Study Chair: Menachem Naheer The Baruch Padeh Medicel Center, Poriya, Tiberias, Israel

Layout table for additonal information
Responsible Party: Menachem Nahir, The baruch Padeh Medical center Identifier: NCT00300833    
Other Study ID Numbers: Aggrastat in AMI.CTIL
First Posted: March 10, 2006    Key Record Dates
Last Update Posted: August 11, 2011
Last Verified: January 2009
Additional relevant MeSH terms:
Layout table for MeSH terms
Myocardial Infarction
Pathologic Processes
Myocardial Ischemia
Heart Diseases
Cardiovascular Diseases
Vascular Diseases
Fibrinolytic Agents
Fibrin Modulating Agents
Molecular Mechanisms of Pharmacological Action
Platelet Aggregation Inhibitors